Impact of changing reimbursement criteria on the use of fluoroquinolones in Belgium

OBJECTIVES: The criteria for the reimbursement of fluoroquinolones changed in Belgium on 1 May 2018. This study aims to quantify the difference in fluoroquinolone use after this change, and to assess the timing and persistence of this effect, both in terms of total reimbursed fluoroquinolone use and...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeulen, Helene, Coenen, Samuel, Hens, Niel, Bruyndonckx, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446932/
https://www.ncbi.nlm.nih.gov/pubmed/34374778
http://dx.doi.org/10.1093/jac/dkab255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446932/
https://www.ncbi.nlm.nih.gov/pubmed/34374778
http://dx.doi.org/10.1093/jac/dkab255

Ejemplares similares